FI71431C - Foerfarande foer bestaemning av malondialdehyd - Google Patents
Foerfarande foer bestaemning av malondialdehyd Download PDFInfo
- Publication number
- FI71431C FI71431C FI793270A FI793270A FI71431C FI 71431 C FI71431 C FI 71431C FI 793270 A FI793270 A FI 793270A FI 793270 A FI793270 A FI 793270A FI 71431 C FI71431 C FI 71431C
- Authority
- FI
- Finland
- Prior art keywords
- sample
- flow
- acid
- malonidialdehyde
- dialysis
- Prior art date
Links
- 238000000502 dialysis Methods 0.000 claims description 12
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000004623 platelet-rich plasma Anatomy 0.000 claims 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 11
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 6
- 229960001138 acetylsalicylic acid Drugs 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- -1 for example Chemical compound 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000008237 rinsing water Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU80437A LU80437A1 (fr) | 1978-10-27 | 1978-10-27 | Procede et dispositif pour le dosage de la malondialdehyde |
| LU80437 | 1978-10-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI793270A7 FI793270A7 (fi) | 1980-04-28 |
| FI71431B FI71431B (fi) | 1986-09-09 |
| FI71431C true FI71431C (fi) | 1986-12-19 |
Family
ID=19729031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI793270A FI71431C (fi) | 1978-10-27 | 1979-10-22 | Foerfarande foer bestaemning av malondialdehyd |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4318706A (da) |
| JP (1) | JPS5589751A (da) |
| AR (1) | AR225295A1 (da) |
| BE (1) | BE879668A (da) |
| CA (1) | CA1121702A (da) |
| CH (1) | CH632845A5 (da) |
| DE (1) | DE2942617C2 (da) |
| DK (1) | DK452879A (da) |
| FI (1) | FI71431C (da) |
| FR (1) | FR2439996A1 (da) |
| GB (1) | GB2036310B (da) |
| IN (1) | IN151553B (da) |
| IT (1) | IT1125601B (da) |
| LU (1) | LU80437A1 (da) |
| MX (1) | MX153877A (da) |
| NL (1) | NL7907787A (da) |
| NO (1) | NO154287C (da) |
| SE (1) | SE441548B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5205988A (en) * | 1989-04-06 | 1993-04-27 | Nihon Bunko Kogyo Kabushiki Kaisha | Apparatus for measuring gaseous aldehyde |
| FR2800874B1 (fr) * | 1999-11-09 | 2001-12-21 | Jean Morelle | Procede permettant de mettre rapidement en evidence le malondialdehyde (mda) dans l'urine, dans les produits alimentaires et cosmetiques |
| KR102614951B1 (ko) * | 2015-12-10 | 2023-12-19 | 삼성전자주식회사 | 색상 변화로 검출 대상의 농도를 측정하기 위한 패드를 제조하는 방법, 그 패드 제작용 용액 및 그 패드를 이용한 스트립 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2797149A (en) * | 1953-01-08 | 1957-06-25 | Technicon International Ltd | Methods of and apparatus for analyzing liquids containing crystalloid and non-crystalloid constituents |
| DE1065635B (da) | 1956-03-23 | |||
| NL130069C (da) | 1962-09-07 | |||
| US3804593A (en) * | 1964-05-25 | 1974-04-16 | Technicon Instr | Automatic analysis apparatus and method |
| US3604814A (en) * | 1969-06-20 | 1971-09-14 | Technicon Corp | Method and apparatus for the sequential analysis of fluid samples |
| JPS5014147A (da) * | 1973-06-08 | 1975-02-14 | ||
| US3876374A (en) * | 1974-03-22 | 1975-04-08 | Technicon Instr | Method and apparatus for automated quantitative fluid analysis |
| SE396819B (sv) * | 1975-12-31 | 1977-10-03 | Gambro Ab | Sett och anordning for bestemning av koncentrationen av en lagmolekyler forening i ett komplext medium genom dialys |
-
1978
- 1978-10-27 LU LU80437A patent/LU80437A1/fr unknown
-
1979
- 1979-10-22 DE DE2942617A patent/DE2942617C2/de not_active Expired
- 1979-10-22 FI FI793270A patent/FI71431C/fi not_active IP Right Cessation
- 1979-10-23 NL NL7907787A patent/NL7907787A/nl not_active Application Discontinuation
- 1979-10-24 GB GB7936880A patent/GB2036310B/en not_active Expired
- 1979-10-24 SE SE7908794A patent/SE441548B/sv not_active IP Right Cessation
- 1979-10-25 IT IT26792/79A patent/IT1125601B/it active
- 1979-10-26 DK DK452879A patent/DK452879A/da not_active Application Discontinuation
- 1979-10-26 BE BE0/197844A patent/BE879668A/fr not_active IP Right Cessation
- 1979-10-26 US US06/088,726 patent/US4318706A/en not_active Expired - Lifetime
- 1979-10-26 MX MX179809A patent/MX153877A/es unknown
- 1979-10-26 IN IN1111/CAL/79A patent/IN151553B/en unknown
- 1979-10-26 CA CA000338590A patent/CA1121702A/en not_active Expired
- 1979-10-26 NO NO793463A patent/NO154287C/no unknown
- 1979-10-26 JP JP13785079A patent/JPS5589751A/ja active Pending
- 1979-10-26 AR AR278640A patent/AR225295A1/es active
- 1979-10-26 FR FR7926684A patent/FR2439996A1/fr active Granted
- 1979-10-26 CH CH963779A patent/CH632845A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO154287B (no) | 1986-05-12 |
| SE441548B (sv) | 1985-10-14 |
| FI793270A7 (fi) | 1980-04-28 |
| DE2942617A1 (de) | 1980-05-08 |
| LU80437A1 (fr) | 1980-05-07 |
| IT1125601B (it) | 1986-05-14 |
| FI71431B (fi) | 1986-09-09 |
| JPS5589751A (en) | 1980-07-07 |
| GB2036310B (en) | 1983-03-02 |
| BE879668A (fr) | 1980-04-28 |
| GB2036310A (en) | 1980-06-25 |
| NO154287C (no) | 1986-08-20 |
| DK452879A (da) | 1980-04-28 |
| DE2942617C2 (de) | 1983-12-29 |
| IT7926792A0 (it) | 1979-10-25 |
| AR225295A1 (es) | 1982-03-15 |
| FR2439996A1 (fr) | 1980-05-23 |
| NL7907787A (nl) | 1980-04-29 |
| IN151553B (da) | 1983-05-21 |
| SE7908794L (sv) | 1980-04-28 |
| MX153877A (es) | 1987-01-30 |
| CH632845A5 (fr) | 1982-10-29 |
| FR2439996B1 (da) | 1984-11-16 |
| US4318706A (en) | 1982-03-09 |
| CA1121702A (en) | 1982-04-13 |
| NO793463L (no) | 1980-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4115538A (en) | Assay kit for cAMP and/or cGMP and method of using the same | |
| Rathbun et al. | Estimation of enzymically produced orthophosphate in the presence of cysteine and adenosine triphosphate | |
| Garg et al. | Mineralocorticoid effects on Na-K-ATPase in individual nephron segments | |
| Cederblad et al. | A method for the determination of carnitine in the picomole range | |
| Rapaport et al. | A simple, specific one-stage assay for plasma thromboplastin antecedent activity | |
| Koepsell et al. | Microdetermination of pyruvic and α-ketoglutaric acids | |
| EP0196533B1 (en) | Coagulant for separating serum or plasma from whole blood for use in blood examination procedures | |
| Raess et al. | A semi-automated method for the determination of multiple membrane ATPase activities | |
| SiLcox et al. | Measurement of inorganic pyrophosphate in biological fluids, elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia | |
| Keenan et al. | Defective platelet lipid peroxidation in myeloproliferative disorders: a possible defect of prostaglandin synthesis | |
| Crowther et al. | The hydrolysis of the condensed phosphates: I. Sodium pyrophosphate and sodium triphosphate | |
| Mori | Direct microcomplexometric analysis of calcium in biological materials | |
| FI71431C (fi) | Foerfarande foer bestaemning av malondialdehyd | |
| Takayama et al. | A simple method for estimation of lipoxygenase and cyclo-oxygenase pathways in human platelets-the use of thiobarbituric acid reaction | |
| Mrzuno et al. | Life span of thrombocytes and erythrocytes in normal and thrombocytopenic calves | |
| Chang | Studies on phagocytosis: I. Uptake of radio-iodinated (131I) human serum albumin as a measure of the degree of phagocytosis in vitro | |
| Wilcox et al. | Use of the Berthelot reaction in the automated analysis of serum urea nitrogen | |
| CN107782808A (zh) | 确定骨化三醇软胶囊溶出度的方法和系统 | |
| Breen et al. | The use of high centrifugal force in separating plasma calcium into its protein-bound and protein-free fractions | |
| Patel | Semimicro method for determination of serum uric acid using EDTA—hydrazine | |
| Waygood | Adaptation of the method of Lowry and Lopez to the estimation of inorganic and organic phosphate in plant extracts | |
| CN101178410A (zh) | 一种用于检测人abo血型的反定型用红细胞试剂盒 | |
| Meng et al. | Effects of multiple infusions of a fat emulsion on blood coagulation, liver function and urinary excretion of steroids in schizophrenic patients | |
| Asrow | Semiautomated enzymic micro methods for blood glucose and lactic acid on a single filtrate | |
| Decker et al. | Responses of cultured cardiac myocytes to lysosomotropic compounds and methylated amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: CONTINENTAL PHARMA INC. |